Sherlock Biosciences is pleased to partner with BARDA on developing next generation, highly accurate, affordable tests for respiratory illnesses
Both firms will develop rapid, home-use diagnostic tests to simultaneously detect SARS-CoV-2, influenza A, and influenza B.